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012.09.00Abstract Introduction: Lymph node (LN) in rheumatoid arthritis (RA) has been the focus of
recent research work; as it is implicated in disease pathogenesis. Power Doppler ultrasonography
(PD-US) is increasingly used for imaging of lymph nodes in conditions other than arthritis.
Aim of the work: To assess the axillary LN in RA using PD-US, and to correlate the ﬁndings to
disease activity.
Patients and methods: Fourteen Consecutive RA patients were subjected to clinical examination
and PD-US of axillary LNs, metacarpophalangeal joints (MCPJs) and wrist joints of the ipsilateral
sides. LNs were assessed for cortex/hilum (CH) area ratio, longitudinal/transverse (LT) axis ratio
and PD signal type. Joints were assessed for grey scale (GS) score and PD score. GS and PD signals
were assigned to each joint in accordance with semi-quantitative 0–3 scales for each.DAS28 score was
used for disease activity assessment.
Results: PD-US detected subclinical LN changes in 24/28 of the examined axillae in RA patients.
Changes included hypertrophy mainly of the cortical area and ampliﬁcation of vascularity of the cen-
tral type. LN changes did not correlate toDAS28 score; rather correlated toGS and PD scores of ipsi-
lateral wrist and MCPJs as assessed by PD-US.7 Abdul Aziz Eissa Street
treet, District 9, Nasr City,
ile: +20 01001228771.
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38 M.A. Ahmed et al.Conclusion: PD-US detects subclinical axillary LN changes in RA patients. These changes do not
correlate toDAS28. Axillary LN changes associate signs of synovitis in ipsilateral wrist andMCPJs as
assessed by PD-US. Owing to the small number of patients enrolled, results presented in this work
should be considered preliminary.
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Rheumatoid arthritis (RA) is a systemic inﬂammatory autoim-
mune disease affecting 1% of the population and is one of the
most prevalent causes of disability worldwide [1]. Early reports
hypothesized that lymphadenopathy, as one of the extra-
articular manifestations of RA, represents participation of
the lymphatic system in pathogenesis of the systemic disease
rather than regional lymphadenopathy secondary to drainage
of the affected joints [2]. Later, Newbould documented the
importance of the immunological events occurring in draining
lymph nodes (LNs) in the development of arthritis in rats. He
found that secondary lesions (generalized adjuvant arthritis
remote from the injection site) do not develop in rats if all
the draining LNs are removed within 5 days of injecting
adjuvant into the foot-pad or ﬂank [3].
Despite the aetiology of RA being still unknown, there is
increasing evidence that innate and adaptive immunity plays
a central role in the disease pathogenesis. Draining LNs is
implicated in the control of cell efﬂux from the joint and
the generation of local immunological responses [4]. How-
ever, most of the evidence of this concept comes from animal
models of arthritis. Li et al. [5] had proposed a model where-
by B cells contribute to arthritis in mice, and possibly RA, by
directly affecting the structure, composition, and function of
joint-draining LNs. They showed that the onset of knee syno-
vitis and focal erosions were paralleled by popliteal LN con-
traction and accumulation of large numbers of B cells in the
lymphatic sinus spaces within the node. Furthermore, other
investigators found that the serum level of cytokines was con-
sistent with the pattern in draining LNs, as examined by ﬂow
cytometry [6].
In an attempt to explore the nature of LN involvement in
RA patients some studies, though a few, were carried out.
These included histology [7], immunocytology [8] and imag-
ing studies. Radiological diagnosis of LNs includes com-
puted tomography (CT) and magnetic resonance imaging
(MRI), however ultrasonography (US) had taken the upper
hand as it is widely available, fast, accurate and with high
resolution [9]. It is to be noted that most reports of US
imaging of LNs were mainly conducted on cancer patients
while few reports in arthritis were available in the literature.
Ju et al., demonstrated the feasibility of phenotyping the
lymphatic drainage function of murine popliteal LN effer-
ents in normal and arthritic joints via in vivo 3-D ultra-
sound imaging [10].
Power Doppler ultrasonography (PD-US) has been used to
document the presence and characteristics of ﬂow in vessels
that are poorly imaged with conventional colour Doppler, to
identify areas of ischaemia, to demonstrate inﬂammatory
hyperemia and to assess the blood ﬂow in tumors [11]. Using
PD-US, Manzo et al. [12] reported signs of axillary LN remod-
elling in RA patients with active disease. Characteristicchanges consisted of hypertrophy of cortex and PD signal
ampliﬁcation in the cortical and hilar regions.
US is more accurate than standard clinical examination at
detecting synovitis [13], and PD technologies further improve
the capability of identifying actively inﬂamed joints [14].
The aim of work was to assess the axillary LNs in RA using
PD-US, and to correlate the ﬁndings to disease activity.
2. Patients and methods
2.1. Patient and control population
This is an observational cross-sectional study. It was carried
out in the period between December 2011 and May 2012 in
Ain Shams University and Al Azhar University Hospitals.
Consecutive RA patients attending the rheumatology out-
patient clinic were invited to participate in the study. Male
and non-pregnant, non-lactating female patients 18 years and
older, diagnosed with RA according to the 2010 rheumatoid
arthritis classiﬁcation criteria [15] were eligible to participate.
Early RA was deﬁned as a case with disease duration of less
than 6 months, while the established cases as disease duration
of 6 months or more. Key exclusion criteria comprised other
autoimmune diseases, neoplastic disease, affection of the upper
extremities such as lymphedema, active skin inﬂammation,
cellulits, recent trauma and oedema, systemic chronic and acute
infections, vaccinations in the 6 months preceding the study
and signiﬁcant concurrent uncontrolled medical condition.
Accordingly, 14 patients were enrolled. Patients were not re-
quired to stop any of their medical treatment. Ten healthy vol-
unteers sex and age matched with patients were recruited as
control. Written consent was obtained from all participants
and the study was approved by the local ethics committee.
2.2. Clinical assessment
Detailed medical history and clinical examination with special
emphasis on the musculoskeletal and the lymphatic systems
was carried out. Disease activity was assessed using DAS28
based on ESR [16]. DAS28 remission was deﬁned as
DAS28 < 2.6 [17].
2.3. Laboratory investigations
Laboratory investigations included IgM RF, anticitrullinated
protein antibody (ACPA), complete blood count (CBC) and
erythrocyte sedimentation rate (ESR) and C reactive protein
(CRP).
2.4. Ultrasonographic examination of lymph nodes
In all cases the radiologist was unaware of clinical and labora-
tory data. Axillary LNs were examined by Alpha 10 Aloka pro-
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10 MHz) broad band width. Both axillae were scanned in trans-
verse and longitudinal directions. Initially, grey scale imaging
was used for detection of a lymph node. If an enlarging lymph
node was found on US, the image at the section of the maxi-
mum size of the lymph node was obtained. The procedure de-
scribed by Song et al. [18] was followed. The hypoechoic
cortical portion and hyperechoic hilar portion were traced on
the US monitor and measured the areas (cm2) of the cortex
and hilum of the LN. Then the area of cortex/area of hilum
was obtained (CH area ratio). The length (cm) of the longitudi-
nal and transverse diameter of the LN was measured, respec-
tively, and the longitudinal diameter/transverse diameter (LT
axis ratio) was calculated PD-US was performed with low-
velocity parameter settings and high gain using a slow scanning
technique. The vascularity of the lymph nodes was evaluated
and classiﬁed into one of three types: (1) peripheral type that
had abundant blood ﬂow at the peripheral cortex of the lymph
node, (2) central type that had abundant blood ﬂow at the hi-
lum of the lymph node or (3) If a node had the same amount
of blood ﬂow in the cortex and hilum, was considered as
peripheral type. According to Song et al. [18] the LN is
considered metastatic when the CH area ratio is greater than
2 and the LT axis ratio is less than 2 on grey scale imaging,
and the blood ﬂow pattern is the peripheral type on power
Doppler imaging.
2.5. Ultrasonographic assessment of joints
US was performed using the same machine for LN examina-
tion with a multifrequency linear 10–18 MHz transducer.
The scanning technique was according to the European league
against rheumatism (EULAR) guidelines [19]. According to
Scire et al. [20] the US assessment included transverse and
longitudinal scanning of medial and lateral dorsal view of
bilateral wrists and metacarpophalangeal joints (MCPJs).
Synovial PD was evaluated by selecting a region that included
bony margins, joint space and a variable view of surrounding
tissues. Pulse repetition frequency was adjusted at the lowest
permissible to maximize sensitivity. Colour gain was set just
below the level that causes the appearance of noise artefacts.
Flow was demonstrated in two perpendicular planes.
Grey-scale (GS) and PD signals were assigned to each joint
in accordance with semi-quantitative 0–3 scales for each [21].
An overall US score for GS and PD signal was calculated at
each US assessment as the sum of GS and PD signal scores
obtained from each joint (range 0–36 for each upper extrem-
ity). For simplicity of results presentation in the present
study, the results of PD-US assessment for the ﬁve MCPJs
of each UE are presented collectively as one unit (the total
score is 15 for GS and for the PD is 15), while the wrist
joint is presented separately (total score for GS is 3 and for
PD is 3).
Statistical analysis was done using the SPSS version 10.0 for
windows. Descriptive statistics was done for continuous
variables by mean, standard deviation (mean ± SD) and
range. Analytical statistics was done using Student’s ‘‘t’’ test
to compare between two independent groups. Correlation
matrix was done using Pearson’s correlation for two variables
in the same group. Chi-square was used for qualitative data.
P value < 0.05 was considered signiﬁcant.3. Results
A total of 14 RA patients (10 females and 4 males) were
enrolled in the study. Their ages ranged between 23 and
48 years and the disease duration between 5 and 60 months
(24.71 ± 18.90). The controls were 7 females and 3 males with
ages ranging between 24 and 46 years. 12/14 patients were on
disease modifying anti-rheumatic drugs (DMARDs) ± low
dose prednisolone while the other two were recently diagnosed.
PD-US examination of the axillary LNs and the ipsilateral
wrist and MCPJs were carried out the same day. On clinical
examination, none of the patients and controls had palpable
axillary lymph nodes. On PD-US examination of the control
subjects, in all cases no axillary LNs were visualized on both
sides. In contrast, PD-US detected LNs in 24/28 of the exam-
ined axillae in RA patients (bilateral in 10 patients and unilat-
eral in 4). On GS imaging, the entire axillary LNs detected had
CH area ratio less than 2 and the LT axis ratio was greater
than 2, while the blood ﬂow pattern was of the central type
on PD imaging (Fig. 1). No other morphological abnormalities
were detected. These changes are consistent with non meta-
static LN changes as classiﬁed by Song et al. [18].
On clinical evaluation, arthritis involving wrist and/or
MCPJs was recorded in 18 out of the 28 examined upper
extremities (UEs). For the 10 control subjects, in all cases on
PD-US examination of the wrist and MCPJs of both sides
the total GS and PD scores were zero .All results of PD-US
for the axillary LNs and the ipsilateral wrist and MCPJs for
the 14 RA patients are shown in Table 1 where results for
the right and left sides are presented separately. Figs. 2 and
3 shows PD-US images for MCPJs and wrist joints, all
obtained from the same patient whose LN images are
illustrated in Fig. 1.
We did not record any difference between male and female
patients concerning any of the PD-US ﬁndings (Table 2).
7/14 patients were RF positive, while only 3/14 patients
were ACPA positive. No signiﬁcant difference was found
between patients positive and patients negative for both RF
and ACPA as regards all the ﬁndings of PD-US examination
for axillary LNs and the ipsilateral wrist and MCPJs
(Table 3). Similarly, disease duration did not correlate to any
of the PD-US ﬁndings (Table 4); changes in axillary LNs
(unilateral in both cases) and the ipsilateral wrist and MCPJs
(total GS score was 6 and 7, total PD score was 11 and 12)
were recorded in the two newly diagnosed cases with disease
duration of less than 6 months. In the 12 patients with
established disease, changes were unilateral in 2 (total GS
scores were 1 and 0, while total PD scores were 2 and 1) and
bilateral in 10 (total Gs score ranged between 4 and 11, while
total PD score ranged between 5–13).
DAS28 score ranged between 2.4 and 5.7 (4.1 ± 1.16)
.There was no signiﬁcant difference in DAS28 score between
patients positive and patients negative for both RF and ACPA
(Table 3) .We recorded non signiﬁcant correlation between
DAS28 score and all the parameters of PD-US examination
for the axillary LNs and the examined joints (Table 4).
PD-US revealed axillary LN changes in the 3 patients (bilat-
eral in 2 and unilateral in 1) who had DAS score < 2.6
(in remission). In those 3 patients PD-US examination of the
ipsilateral joints revealed total scores ranging between 1 and
7 for the GS and between 1 and 9 for the PD.CBC for those
Table 1 The results of PD-US ﬁndings of axillary lymph nodes and ipsilateral wrist and MCPJs.
Right UEs N= 14 Left UEs n= 14 t p
Mean ± SD Range(min–max) Mean ± SD Range(min–max)
LN CH area ratio 0.67 ± 0.38 0.00–1.39 0.57 ± 0.27 0.00–0.83 0.40 0.69
LN LT axis ratio 2.00 ± 0.87 0.00–2.72 2.10 ± 0.92 0.00–3.00 0.71 0.49
Wrist GS score 1.43 ± 0.76 0.00–2.00 1.86 ± 0.95 0.00–3.00 1.79 0.09
Wrist PD score 1.71 ± 0.47 0.00–2.00 2.07 ± 0.92 0.00–3.00 1.54 0.14
MCPJs GS score 4.50 ± 2.74 0.00–9.00 4.07 ± 2.06 0.00–7.00 0.00 1.0
MCPJs PD score 5.50 ± 2.93 1.00–11.00 5.14 ± 2.41 1.00–8.00 0.09 0.94
Total GS score for the UEs 5.93 ± 3.34 0.00–11.00 6.00 ± 2.99 0.00–10.00 0.58 0.57
Total PD score for the UEs 7.21 ± 3.26 1.00–13.00 7.29 ± 3.36 1.00–12.00 0.51 0.61
LN, lymph node; CH, cortex/hilum; LT, longitudinal/transverse; GS, grey scale; PD, power Doppler; MCIJs, metacarpophalangeal joints; UEs,
upper extremities; SD, standard deviation.
A B
Figure 1 Image of ultrasonographic grey scale appearance of axillary lymph node (A), longitudinal/transverse axis ratio is 2.19 and the
cortex/hilum area ratio is 0.64. Power Doppler ultrasonography image of the same lymph node (B) showing increased central vascularity
(arrows), power Doppler score is 2. The image was obtained from a 37 male patients with 4.2 DAS 28 score.
A B
Figure 2 Power Doppler ultrasonography image of the metacarpophalangeal joint, grey scale score is 1(A), power Doppler score is 1(B).
40 M.A. Ahmed et al.3 patients in remission did not show any abnormality (total
leukocyte count was 8.1, 7.2 and 6.6 · 103/mm3 – red blood
cell count was 6.9, 5.7 and 5.2 · 106/mm3 – platelet count
was 232,334 and 298 · 103/mm3 – haemoglobin (g/dl) was
14.9, 13.1 and 12.2)
On the other hand, in 2 patients with DAS28 score of 5.6
and 5.7, on PD-US unilateral absence of axillary LN were
detected. For those 2 patients, on PD-US examination of the
ipsilateral wrist and MCPJs total score for GS was 0 and for
PD was 2.
Table 5 shows the signiﬁcant correlation between the LN
CH area ratio and the LN LT axis ratio of axillary LNs andthe GS and PD scores of the ipsilateral wrist and MCPJs. In
other words, PD-US assessment documented the signiﬁcant
correlation between the axillary LN changes and evidence of
inﬂammation in the ipsilateral wrist and MCPJs.
4. Discussion
The present study documents the presence of subclinical axil-
lary LN involvement in RA, which is not correlated to disease
activity, as judged by DAS28; rather it is correlated to the de-
gree of PD-US evidence of synovitis in the ipsilateral wrist and
MCPJs.
A B
Figure 3 Power Doppler ultrasonography image of the wrist joint, grey scale score is 2(A) and power Doppler score is 2(A).
Table 2 Comparison between male and female patients regarding PD-US ﬁndings.
Male n= 4 mean ± SD Female n= 10 mean ± SD t p
R CH area ratio 0.74 ± 0.37 0.58 ± 0.43 0.64 0.53
R LT axis ratio 2.14 ± 0.57 1.76 ± 0.93 0.79 0.45
Total GS score R UEs 7.25 ± 1.50 4.60 ± 2.95 1.68 0.12
Total PD score R UEs 8.50 ± 0.58 6.00 ± 2.58 1.87 0.09
L CH area ratio 0.48 ± 0.37 0.61 ± 0.24 0.830 0.42
L LT axis ratio 1.85 ± 1.92 2.19 ± 0.78 0.62 0.55
Total GS score L UEs 4.75 ± 4.69 6.50 ± 2.72 0.99 0.34
Total PD score L UEs 6.00 ± 4.16 7.80 ± 3.08 0.90 0.39
LN, lymph node; CH, cortex/hilum; LT, longitudinal/transverse; GS, grey scale; PD, power Doppler; R, right; L, left; UEs, upper extremities;
SD, standard deviation.
Table 3 Comparison between patients positive and patients negative for rheumatoid factor and anti cyclic protein antibody.
RF positive
N= 7 mean ± SD
RF negative
N= 7 mean ± SD
t p ACPA positive
n= 3 mean ± SD
ACPA negative
n= 11 mean ± SD
t p
DAS 28 score 3.83 ± .94 4.37 ± 1.37 0.87 0.40 4.60 ± 0.78 3.96 ± 1.24 0.83 0.42
DD (months) 20.14 ± 14.31 29.29 ± 19.10 1.01 0.33 27.33 ± 28.31 24.0 ± 14.43 0.78 0.29
R CH area ratio 0.68 ± 0.46 0.58 ± 0.37 0.43 0.67 0.60 ± 0.20 0.63 ± 0.43 0.77 0.31
R LT axis ratio 1.83 ± 0.81 1.90 ± 0.84 0.17 0.87 2.39 ± 0.30 1.90 ± 0.95 0.86 0.41
L CH area ratio 0.64 ± 0.16 0.51 ± 0.36 0.90 0.39 0.51 ± 0.15 0.59 ± 0.30 0.47 0.65
L LT axis ratio 2.41 ± 0.29 1.87 ± 1.23 1.31 0.21 2.36 ± 0.77 2.02 ± 1.03 0.56 0.59
Total GS score for R UEs 6.43 ± 3.05 4.03 ± 2.36 1.47 0.17 9.00 ± 1.00 5.09 ± 3.27 1.99 0.07
Total PD score for R UEs 7.57 ± 2.07 5.86 ± 2.27 1.34 0.21 10.00 ± 1.73 6.45 ± 3.20 1.81 0.10
Total GS score for L UEs 6.57 ± 2.07 5.43 ± 3.78 0.70 0.50 8.00 ± 2.65 5.46 ± 2.95 1.35 0.20
Total PD score for L UEs 7.57 ± 2.51 7.0 ± 4.24 0.31 0.76 9.33 ± 2.89 6.73 ± 3.38 1.21 0.25
RF, rheumatoid factor; ACPA, anticitrullinated protein antibody; DD, disease duration; LN, lymph node; CH, cortex/hilum; LT, longitudinal/
transverse; GS, grey scale; PD, power Doppler; R, right; L, left; UEs, upper extremities; SD, standard deviation.
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and DAS28 implies that these changes do not associate disease
activity. However, PD-US study ﬁndings for axillary LNs cor-
related to the scores given for GS and PD for the ipsilateral
wrist and MCPJs i.e., LN ﬁndings correlated to the degree
of synovitis as detected by PD-US. Previous studies have
documented that joint US can independently evaluate disease
activity in RA patients [22]. Furthermore, achievement of
clinical remission itself may not coincide with true suppression
of inﬂammation; as patients in clinical remission may continue
to have synovitis detectable using US [23]. It has been
proposed that LN involvement in RA is a dynamic phenome-non related to disease activity and is reversible upon anti-
inﬂammatory treatment [12]. The present study is of the cross
sectional design; our results cannot directly go with this con-
cept. However, the positive correlation between LN changes
(CH area ratio and LT axis ratio) and the PD-US scores for
the ipsilateral joints could provide some support to that
theory.
All LNs showed the criteria of non malignant LNs as clas-
siﬁed by Song et al. [18]. The detected LNs had CH area ratio
of 0.67 ± 0.38 on the right side and 0.57 ± 0.27 on the left
side, indicating more selective hypertrophy of the cortical re-
gion which includes the paracortical area, known enriched in
Table 4 The correlation of disease duration and DAS28 score to LN changes and PD-US ﬁndings of the ipsilateral wrist and MCPJs
for the 28 UEs.
LN CH area ratio LN LT axis ratio Total GS score for the UEs Total PD score for the UEs
DD in months
r 0.24 0.15 0.03 0.13
p 0.22 0.45 0.88 0.51
DAS28 score
r 0.13 0.13 0.056 0.01
p 0.53 0.52 0.78 0.98
DD, disease duration; CH, cortex/hilum; LT, longitudinal/transverse; GS, grey scale; PD, power Doppler; MCIJs, metacarpophalangeal joints;
UEs, upper extremities.
Table 5 The correlation between PD-US ﬁndings of axillary LNs and ipsilateral wrist and MCPJs for the right and left upper
extremities.
Total GS score for the UEs Total PD score for the UEs
R L R L
LN CH area ratio
r 0.615** 0.62* 0.54* 0.57*
p <0.001 0.019 0.003 0.033
LN LT axis ratio
r 0.77** 0.77** 0.73** 0.71**
p <0.001 0.001 <0.001 0.005
LN, lymph node; CH, cortex/hilum; LT, longitudinal/transverse; GS, grey scale; PD, power Doppler; MCIJs, metacarpophalangeal joints; R,
right; L, left; UEs, upper extremities.
** Correlation is signiﬁcant at the < 0.01 level (2-tailed).
* Correlation is signiﬁcant at the < 0.05 level (2-tailed).
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CD21hi B-cells (B-in) into the paracortical sinus space of the
draining LNs was illustrated In TNF transgenic mice. Collapse
of some draining LNs was explained by translocation of the
expanded B-in population to the lumen of the lymphatic
vessels [25]. Anti CD20 B depletion therapy was found to
ameliorate TNF transgenic mouse model of RA; it clears
follicular CD21hi and CD20+B cells from the regional nodes.
CD21hi and CD20+B are polyclonal B cell speciﬁcally
restricted to LN draining inﬂamed arthritic joints. Accord-
ingly, B cells were proposed to contribute to arthritis in mice
by directly affecting the structure, composition and function
of joint draining LNs [5]. LN changes in the present study
included increased central LN blood ﬂow as detected by PD,
which is similar to the ampliﬁcation of regional blood ﬂow
to regional LNs that occurs spontaneously in TNF transgenic
mice [26]. PD ampliﬁcation reversal was recorded to associate
good and moderate EULAR response to therapy while cortical
hypertrophy persists [12].
In the present study, LN changes were recorded in early as
well as established cases. This enforces the theory that LN
changes are mostly correlated to the degree of activity of the
ipsilateral joints regardless of other factors including disease
duration. The anticitrulline response, an early event in RA
development, was postulated to initiate in secondary lymphoid
tissues or bone marrow. Thereafter, localization of the inﬂam-
matory response occurs in the joint [27]. Accordingly, detec-
tion of LN changes in early cases is expected.The recorded changes of the axillary LNs did not correlate
to RF and ACPA status. This could indicate that LN involve-
ment is not an intrinsic feature of RA sero-positive subset [12].
LN involvement could be related to other mechanisms of dis-
ease development, not speciﬁcally including RF and ACPA.
Limitations of the study are the small number of patients;
accordingly the results reported in this work are considered
preliminary. The cross sectional design employed in the study
does not allow observation of the response to treatment in the
same patient over time. We only evaluated axillary LNs; con-
sidering assessment of other LN groups using the same tech-
nique could reveal interesting data which may support our
results. The ﬁndings obtained by assessment of the ipsilateral
wrist and MCPJs were correlated with axillary LN changes,
it would be appropriate for further studies to also include
other joints of the UE. Follow up could be vital in clarifying
the nature of LN involvement in RA. Absence of LNs as de-
tected by PD-US in the control subjects could indicate that this
phenomenon is disease related. However, the current study
cannot relate LN involvement to deﬁnite aspects of the disease
pathogenesis. Further studies collaborating PD-US with im-
muno-pathology studies are of interest. Longitudinal studies
could explore the response of LNs to therapy.
In conclusion, using PD-US subclinical changes in axillary
LNs are detected in RA patients. Major changes include
hypertrophy of the cortical area with ampliﬁcation of the cen-
tral vascularity. These changes do not correlate disease activity
as assessed by DAS28; rather correlate well with PD-US evi-
Axillary lymph node in rheumatoid arthritis: Does it associate disease activity 43dence of synovitis in the ipsilateral wrist and MCPJs. LN
changes are recorded in early as well as established cases
whether positive or negative to RF and ACPA. The results ob-
tained from this study are preliminary and further work
employing larger samples, studying different LN groups and
of different study designs are recommended.
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